MET alterations in advanced pulmonary sarcomatoid carcinoma

Pulmonary sarcomatoid carcinoma (PSC) is a rare subset of NSCLC that accounts for about 0.5-1% of all primary lung carcinoma, and its malignant biological behavior is more aggressive than other pathological types of lung cancer. Recent studies have reported a variety of gene mutations associated wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Gong, Chen, Xiong, Huihua, Qin, Kai, Wang, Jianhua, Cheng, Yi, Zhao, Jing, Zhang, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9539670/
https://www.ncbi.nlm.nih.gov/pubmed/36212500
http://dx.doi.org/10.3389/fonc.2022.1017026

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9539670/
https://www.ncbi.nlm.nih.gov/pubmed/36212500
http://dx.doi.org/10.3389/fonc.2022.1017026

Ejemplares similares